Literature DB >> 35012926

Third COVID-19 vaccine dose with BNT162b2 in patients with ANCA-associated vasculitis.

Claudius Speer1,2, Maximilian Töllner3, Louise Benning3, Katrin Klein3, Marie Bartenschlager4, Christian Nusshag3, Florian Kälble3, Paula Reichel3, Paul Schnitzler4, Martin Zeier3, Christian Morath3, Wilhelm H Schmitt5, Raoul Bergner6, Ralf Bartenschlager4,7, Matthias Schaier3.   

Abstract

Entities:  

Keywords:  COVID-19; autoimmune diseases; rituximab; vaccination

Mesh：

Substances：

Year:  2022        PMID： 35012926     DOI： 10.1136/annrheumdis-2021-221747

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

Review 1.  Booster COVID-19 Vaccines for Immune-Mediated Inflammatory Disease Patients: A Systematic Review and Meta-Analysis of Efficacy and Safety.

Authors:  Ainsley Ryan Yan Bin Lee; Shi Yin Wong; Sen Hee Tay
Journal:  Vaccines (Basel)       Date:  2022-04-22

2.  Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases.

Authors:  George E Fragoulis; Anastasios Karamanakos; Aikaterini Arida; Vasiliki-Kalliopi Bournia; Gerasimos Evangelatos; Antonis Fanouriakis; Kalliopi Fragiadaki; Evrydiki Kravvariti; Katerina Laskari; Stylianos Panopoulos; Nikolaos Papazoglou; Maria Pappa; Maria G Tektonidou; Petros P Sfikakis
Journal:  RMD Open       Date:  2022-03

3.  Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients.

Authors:  Louise Benning; Katrin Klein; Christian Morath; Marie Bartenschlager; Heeyoung Kim; Mirabel Buylaert; Marvin Reineke; Maximilian Töllner; Christian Nusshag; Florian Kälble; Paula Reichel; Paul Schnitzler; Martin Zeier; Caner Süsal; Ralf Bartenschlager; Matthias Schaier; Claudius Speer
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

4.  Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.

Authors:  Louise Benning; Christian Morath; Marie Bartenschlager; Heeyoung Kim; Marvin Reineke; Jörg Beimler; Mirabel Buylaert; Christian Nusshag; Florian Kälble; Paula Reichel; Maximilian Töllner; Matthias Schaier; Katrin Klein; Vladimir Benes; Tobias Rausch; Susanne Rieger; Maximilian Stich; Burkhard Tönshoff; Niklas Weidner; Paul Schnitzler; Martin Zeier; Caner Süsal; Thuong Hien Tran; Ralf Bartenschlager; Claudius Speer
Journal:  Am J Transplant       Date:  2022-04-18       Impact factor: 9.369

5.  Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS.

Authors:  Kate I Stevens; Eleni Frangou; Jae I L Shin; Hans-Joachim Anders; Annette Bruchfeld; Ulf Schönermarck; Thomas Hauser; Kerstin Westman; Gema M Fernandez-Juarez; Jürgen Floege; Dimitrios Goumenos; Kultigin Turkmen; Cees van Kooten; Stephen P McAdoo; Vladimir Tesar; Mårten Segelmark; Duvuru Geetha; David R W Jayne; Andreas Kronbichler
Journal:  Nephrol Dial Transplant       Date:  2022-07-26       Impact factor: 7.186

6.  COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study.

Authors:  Malcolm Risk; Salim S Hayek; Elena Schiopu; Liyang Yuan; Chen Shen; Xu Shi; Gary Freed; Lili Zhao
Journal:  Lancet Rheumatol       Date:  2022-08-16

7.  COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases.

Authors:  Chiara Cardelli; Teresita Caruso; Chiara Tani; Federico Pratesi; Rosaria Talarico; Federica Di Cianni; Nazzareno Italiano; Elenia Laurino; Michele Moretti; Giancarlo Cascarano; Michele Diomedi; Luca Gualtieri; Rossella D'Urzo; Paola Migliorini; Marta Mosca
Journal:  Rheumatology (Oxford)       Date:  2022-05-24       Impact factor: 7.046

8.  Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid.

Authors:  Louise Benning; Christian Morath; Tessa Kühn; Marie Bartenschlager; Heeyoung Kim; Jörg Beimler; Mirabel Buylaert; Christian Nusshag; Florian Kälble; Marvin Reineke; Maximilian Töllner; Matthias Schaier; Katrin Klein; Antje Blank; Paul Schnitzler; Martin Zeier; Caner Süsal; Ralf Bartenschlager; Thuong Hien Tran; Claudius Speer
Journal:  Front Med (Lausanne)       Date:  2022-08-18

9.  Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 Therapy.

Authors:  Maximilian Töllner; Claudius Speer; Louise Benning; Marie Bartenschlager; Christian Nusshag; Christian Morath; Martin Zeier; Caner Süsal; Paul Schnitzler; Wilhelm Schmitt; Raoul Bergner; Ralf Bartenschlager; Hanns-Martin Lorenz; Matthias Schaier
Journal:  J Clin Med       Date:  2022-03-21       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.